Prevalence of somatic-mental multimorbidity and its prospective association with disability among older adults in China by Li, Haibin et al.
Edith Cowan University 
Research Online 
ECU Publications Post 2013 
1-1-2020 
Prevalence of somatic-mental multimorbidity and its prospective 
association with disability among older adults in China 
Haibin Li 
Anxin Wang 
Qi Gao 
Xiaonan Wang 
Yanxia Luo 
See next page for additional authors 
Follow this and additional works at: https://ro.ecu.edu.au/ecuworkspost2013 
 Part of the Medicine and Health Sciences Commons 
10.18632/aging.103070 
Li, H., Wang, A., Gao, Q., Wang, X., Luo, Y., Yang, X., ... & Guo, X. (2020). Prevalence of somatic-mental multimorbidity 
and its prospective association with disability among older adults in China. Aging (Albany NY), 12(8), 7218. 
https://doi.org/10.18632/aging.103070 
This Journal Article is posted at Research Online. 
https://ro.ecu.edu.au/ecuworkspost2013/8434 
Authors 
Haibin Li, Anxin Wang, Qi Gao, Xiaonan Wang, Yanxia Luo, Xinghua Yang, Xia Li, Wei Wang, Deqiang Zheng, 
and Xiuhua Guo 
This journal article is available at Research Online: https://ro.ecu.edu.au/ecuworkspost2013/8434 
 www.aging-us.com 7218 AGING 
INTRODUCTION 
 
China, a large middle-income country, has the world’s 
largest aging population [1, 2]. It is estimated that the 
number of Chinese people aged 65 years or older will 
reach 400 million by 2050, 150 million of whom will 
be aged 80 years or older [3]. Currently, stroke, 
ischemic heart disease, and chronic obstructive 
pulmonary disease are the top three causes of years of 
life lost in China [4]. Somatic multimorbidity (defined 
as two or more chronic diseases [5]) is common and  
 
prevalent among older Chinese adults. The 
approximate prevalence of multimorbidity has been 
reported to be between 10% and 90% in different 
study populations in China [6–9]. Numerous 
epidemiologic studies have reported that multi-
morbidity is associated with reduced quality of life 
[10], compromised self-rated health [11], depressive 
symptoms [12], cognitive impairment [13], disability 
[14], and all-cause mortality [15]. In addition, 
multimorbidity leads to more complex economic and 
healthcare challenges [6]. 
www.aging-us.com AGING 2020, Vol. 12, No. 8 
Research Paper 
Prevalence of somatic-mental multimorbidity and its prospective 
association with disability among older adults in China 
 
Haibin Li1,2, Anxin Wang3, Qi Gao1,2, Xiaonan Wang1,2, Yanxia Luo1,2, Xinghua Yang1,2, Xia Li4, Wei 
Wang5, Deqiang Zheng1,2, Xiuhua Guo1,2 
 
1Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, 
China 
2Beijing Municipal Key Laboratory of Clinical Epidemiology, Capital Medical University, Beijing, China 
3Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University Beijing, China 
4Department of Mathematics and Statistics, La Trobe University, Melbourne, Victoria, Australia 
5Global Health and Genomics, School of Medical Sciences and Health, Edith Cowan University, Perth, Western 
Australia, Australia 
 
Correspondence to: Xiuhua Guo, Deqiang Zheng; email: statguo@ccmu.edu.cn, dqzheng@ccmu.edu.cn  
Keywords: multimorbidity, somatic conditions, mental conditions, disability 
Received: November 26, 2019 Accepted: March 29, 2020  Published: April 25, 2020 
 
Copyright: Li et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC 
BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and 
source are credited. 
 
ABSTRACT 
 
We aimed to identify prevalent somatic-mental multimorbidity (SMM) and examine its prospective 
association with disability among a nationally representative sample. A total of 6728 participants aged 60 
years and older in the China Health and Retirement Longitudinal Study were included. A total of 14 somatic 
or mental conditions were assessed in 2013. SMM was defined as any combination of two or more conditions 
in which at least one condition was somatic and at least one condition was mental. Disability risk was 
measured using the combined Activities of Daily Living (ADL)-Instrumental Activities of Daily Living (IADL) 
index (range 0–11; higher index indicates higher disability) in 2013 and 2015. Overall, the prevalence of SMM 
was 35.7% (95% confidence interval (CI): 34.1%-37.3%) in 2013. After adjustment for sociodemographic 
characteristics, lifestyles and baseline ADL-IADL index, over a maximum follow-up period of 2 years, SMM 
was associated with a 2.61 (95% CI: 2.12-3.22)-fold increase in ADL-IADL disability risk compared with that of 
healthy participants. In conclusion, SMM was prevalent in older Chinese adults, and it was associated with a 
higher risk of prospective disability. 
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A growing number of studies have found that mental 
health conditions such as depression or anxiety are 
prevalent and commonly co-occur with chronic somatic 
conditions among the elderly [14, 16–21]. This 
phenomenon is termed somatic-mental multimorbidity 
(SMM). Among the elderly, cognitive impairment and 
depression are major mental conditions [22, 23]. A 
recent meta-analysis reported that nearly one-third of 
participants with cognitive impairment suffered from 
depression [24]. The prevalence of SMM was estimated 
to be 13.9% in men and 21.1% in women in 2010 
among 138,858 American residents aged 65 years or 
older [20]. To the best of our knowledge, little is known 
about the prevalence and pattern of combinations of 
somatic and mental conditions in developing countries, 
particularly in China. 
 
Several previous studies have demonstrated that somatic 
multimorbidity increases the risk of disability among 
the elderly [14, 19, 21, 25–29]. However, the impact of 
SMM on disability has been less well described [14, 
21]. Recently, Vetrano et al. reported that the co-
occurrence of cardiovascular and neuropsychiatric 
chronic diseases increased disability over 9 years of 
follow-up [21]. In addition, Quinones et al. investigated 
the impact of different combinations of SMM on 
disability using a nationally representative prospective 
cohort study [14]. However, those studies were 
conducted in Western populations [14, 21]. Little is 
known about the pattern of SMM and its impact on 
prospective disability in the Chinese population, which 
has a higher prevalence of somatic multimorbidity. 
 
The aim of this study is to (1) estimate the prevalence 
and patterns of SMM by age, sex, residence, and 
geographical region in a nationally representative 
Chinese population and (2) explore the association of 
different combinations of somatic and mental conditions 
on prospective disability in older adults. 
 
RESULTS 
 
Sample characteristics 
 
A total of 6728 older adults aged 60 years or older at 
baseline was included for the current analysis. Table 1 
presents the characteristics of the sample. The mean age 
was 67.6 ± 6.3 years, and 50.3% of the participants 
were male. Overall, 50.9% of the participants had 
somatic multimorbidity, and the prevalence of arthritis 
was highest (39.9%), followed by hypertension 
(35.9%). In addition, 33.8% of participants were 
depressed, and 19.2% had cognitive impairment. Of the 
participants, 8.4% had both depression and cognitive 
impairment. At baseline, 39.7% of participants had 
difficulty in at least one ADL-IADL impairment. 
Prevalence of SMM 
 
Table 2 summarizes the sex-specific prevalence of 
SMM by age and residence. The overall prevalence of 
SMM was 35.7% (95% confidence interval (CI): 
34.1%-37.3%) in China in 2013. Overall, females had a 
higher prevalence of SMM than males (44.6% vs. 
27.0%, p-value <0.001), and this difference was 
significant across different age groups and residence. 
Among males, the prevalence of SMM was highest in 
the 70-74 age group compared to those aged 60-64 
years (32.8% vs. 24.6%, p-value=0.001), while the 
prevalence of SMM was highest in those aged 75 years 
or older compared to those aged 60-64 years among 
females (47.6% vs. 41.6%, p-value=0.039). This 
difference was more obvious when participants were 
stratified by residence. The SMM prevalence was also 
higher among one who lived in rural areas than among 
persons who lived in urban areas in both males (31.9% 
vs. 20.8%, p-value <0.001) and females (52.9% vs. 
34.0%, p-value <0.001). Figure 1 shows the age-
adjusted prevalence of SMM by geographic location in 
China. The Southwest region (46.8%) had the highest 
prevalence of SMM, followed by the Northwest 
(43.6%), North (34.1%), South-Central (32.8%), and 
East region (32.5%), while participants who lived in the 
Northeast region (25.7%) had the lowest SMM 
prevalence. 
 
SMM and prospective disability 
 
Table 3 reports the association between multimorbidity 
combinations and the ADL-IADL index in 2015. Over a 
maximum follow-up period of 2 years, SMM was 
associated with a 4.49 (95% CI: 3.60-5.59)-fold 
increase in ADL-IADL risk in the unadjusted model and 
a 2.61 (95% CI: 2.12-3.22)-fold increase in ADL-IADL 
in the adjusted model compared with healthy 
participants. 
 
Stratified analyses by age, sex, and residence are also 
shown in Table 3. In the adjusted model compared with 
healthy participants, SMM was associated with a 3.05 
(95% CI: 2.29-4.07)-fold increase in ADL-IADL among 
adults aged 60-69 years, while SMM was associated 
with a 2.10 (95% CI: 1.55-2.85)-fold increase in ADL-
IADL among adults aged 70 years or older. Among 
males, SMM was associated with a 2.84 (95% CI: 2.15-
3.75)-fold increase in ADL-IADL, while SMM was 
associated with a 2.36 (95% CI: 1.77-3.16)-fold 
increase in ADL-IADL in females. Among adults who 
lived in urban areas, SMM was associated with a 2.36 
(95% CI: 1.61-3.47)-fold increase in ADL-IADL, while 
SMM was associated with a 2.36 (95% CI: 2.23-3.47)-
fold increase in ADL-IADL among adults who lived in 
rural areas. The overall p values for interaction for the 
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Table 1. Baseline characteristics of china health and retirement  
longitudinal study (Unweighted). 
Variable Value (n=6728) 
Age-years-Mean ± SD 67.6 ± 6.3 
Male, n (%) 3383 (50.3) 
Less than lower secondary education, n (%) 6292 (93.5) 
Married, n (%) 5231 (77.8) 
Rural area, n (%) 4256 (63.3) 
Geographical region, n (%) 
    East 2142 (31.8) 
   North 745 (11.1) 
   North-East 446 (6.6) 
   North-West 466 (6.9) 
   South-Central 1592 (23.7) 
   South-West 1337 (19.9) 
Current smoker, n (%) 936 (13.9) 
Current drinker, n (%) 2179 (32.4) 
Hypertension, n (%)  2417 (35.9) 
Diabetes, n (%)  616 (9.2) 
Cancer, n (%)  72 (1.1) 
Lung disease, n (%)  1008 (15.0) 
Heart disease, n (%)  1176 (17.5) 
Stroke, n (%)  260 (3.9) 
Arthritis, n (%)  2683 (39.9) 
Dyslipidemia, n (%)  916 (13.6) 
Liver disease, n (%)  316 (4.7) 
Kidney disease, n (%)  509 (7.6) 
Stomach disease, n (%)  1719 (25.6) 
Asthma, n (%)  459 (6.8) 
No. of somatic conditions, n (%) 
    0 1437 (21.4) 
   1 1868 (27.8) 
   2+ 3423 (50.9) 
Depression, n (%) 2274 (33.8) 
Cognitive impairment, n (%) 1291 (19.2) 
No. of mental conditions, n (%)  
    0 3730 (55.4) 
   1 2431 (36.1) 
   2 567 (8.4) 
ADL–IADL index in 2013-Mean ± SD 1.0 ± 1.8 
   1+, n (%) 2667 (39.7) 
 
association between multimorbidity combination groups 
and prospective disability was 0.396 for age, 0.481 for 
sex, and 0.007 for residence. 
 
In the sensitivity analysis, the association between 
SMM and the ADL-IADL index did not substantially 
change after excluding incontinence from the ADL-
IADL index (eβ=2.52, 95% CI: 2.06-3.08) 
(Supplementary Table 1). The results after further 
adjustment for body mass index (BMI) were consistent 
with the results of our main analyses (eβ=2.52, 95% 
CI: 2.06-3.08) (Supplementary Table 1). When 
participants who had at least one impairment in the 
ADL-IADL index in 2013 were excluded, SMM was 
associated with a 2.36 (95% CI: 1.77-3.16) times 
greater ADL-IADL risk in adjusted models 
(Supplementary Table 2). 
 
DISCUSSION 
 
This study estimated the prevalence of SMM and 
investigated the association between SMM and 
prospective ADL-IADL disability in a nationally 
representative sample. Overall, we found that 35.7% of 
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Table 2. Prevalence (per 100 people) of somatic–mental multimorbidity by age-sex-and urban/rural residence. 
Age (y) 
Male  Female 
Prevalence  Prevalence 
Unweighted, 
n (%) 
Weighted*,  
% (95% CI) 
 
Unweighted, 
n (%) 
Weighted*,  
% (95% CI) 
All urban/rural residence 
60-64 1354 350 (25.9) 24.6 (22.0-27.3)  1339 574 (42.9) 41.6 (38.5-44.8) 
65-69 895 247 (27.6) 25.3 (21.6-29.3)  907 429 (47.3) 46.1 (41.1-51.1) 
70-74 609 199 (32.7) 32.8 (28.7-37.2)  566 275 (48.6) 45.6 (40.9-50.3) 
75+ 525 163 (31.1) 29.0 (23.4-35.3)  533 264 (49.5) 47.6 (42.5-52.7) 
All ages 3383 959 (28.4) 27.0 (24.9-29.2)  3345 1542 (46.1) 44.6 (42.2-47.0) 
Urban residence 
60-64 492 96 (19.5) 18.3 (14.7-22.5)  495 166 (33.5) 31.7 (27.0-37.0) 
65-69 310 73 (23.6) 19.6 (14.1-26.5)  301 106 (35.2) 36.4 (25.6-48.6) 
70-74 226 60 (26.6) 29.1 (22.6-36.5)  225 75 (33.3) 32.1 (25.4-39.7) 
75+ 197 47 (23.9) 20.0 (12.6-30.3)  226 91 (40.2) 36.9 (29.8-44.8) 
All ages 1225 276 (22.5) 20.8 (17.7-24.3)  1247 438 (35.1) 34.0 (29.8-38.4) 
Rural residence 
60-64 862 254 (29.5) 29.2 (25.7-32.9)  844 166 (33.5) 48.9 (44.9-52.9) 
65-69 585 174 (29.7) 29.7 (25.8-33.9)  606 106 (35.2) 52.8 (48.4-57.1) 
70-74 383 139 (36.3) 35.7 (30.5-41.3)  341 75 (33.3) 57.7 (51.9-63.4) 
75+ 328 116 (35.4) 37.9 (32.1-44.0)  307 91 (40.2) 57.7 (51.0-64.1) 
All ages 2158 683 (31.7) 31.9 (29.4-34.5)  2098 438 (35.1) 52.9 (50.2-55.5) 
*Accounted for the complex survey design. 
 
Chinese adults aged ≥60 years suffered SMM. 
Moreover, SMM was independently associated with 
greater perspective ADL-IADL disability 2 years later 
when compared with healthy participants free of 
chronic and mental conditions. 
 
This study demonstrated the clinical pattern of SMM 
combinations in China, which is the largest aging 
population in the world. Our findings are consistent 
with previous studies showing that SMM prevalence 
was higher in older age groups, females, and those 
living in rural areas [8, 19, 20, 30, 31]. The prevalence 
of SMM in our study was higher than that in the 
Rochester Epidemiology Project of the US population 
among adults aged ≥ 60 years (35.7% vs. 17.2%), 
especially among women (44.6% in China vs. 20.4% in 
the US) [20]. Additionally, we found that older adults 
who lived in the rural area and Southwest region had a 
higher rate of SMM compared with those living in other 
parts of China. This contributes to public health policy 
and practice to rationally allocate medical resources in 
China. 
 
Although the prevalence of disability in ADLs and 
IADLs among older Chinese adults decreased from 
1997 to 2006 [32, 33], disability still causes major 
challenges both for health systems and clinicians in 
China. Prior studies have shown that chronic 
multimorbidity is an established risk factor for disability 
[26–29, 34]. Based on the data from the CHARLS 
(2013), Qian et al. confirmed that chronic multi-
morbidity was associated with a 3.66-fold increased risk 
of disability in ADLs and a 2.00-fold increased risk of 
disability in IADLs among adults aged ≥ 45 years who 
had hypertension [35]. However, the contribution of 
SMM to disability was understudied in this study. To 
the best of our knowledge, our study was the first to 
explore the impact of SMM combinations on disability 
in a nationally representative cohort study in China. The 
current results support previous findings suggesting that 
SMM is associated with an increased risk of disability 
[14, 21, 25, 36]. In the Swedish National Study of 
Aging and Care in Kungsholmen (SNAC-K) with a 9-
year follow-up, SMM was associated with a 0.27 
decrease in the number of ADLs per year [21]. Notably, 
only 4.20% (100 of 2385) of the sample had SMM 
among older adults ≥ 60 years in SNAC-K study. The 
statistical power seemed to be low. In addition, in the 
National Health and Aging Trends Study, older adults 
with depression and cognitive impairment were 
associated with a 1.34 times greater risk of disability on 
the ADL-IADL index [14]. This association was 
consistent with our findings. This study showed that 
different patterns of somatic and mental morbidity had 
different impacts on disability. Given the rapidly 
developing multimorbidity and disability in the elderly, 
it is clinically useful to assess the impact of specific 
multimorbidity combinations on disability. 
 www.aging-us.com 7222 AGING 
A major strength of this study was that it was, to the 
best of our knowledge, the largest prospective 
nationally representative sample in China to date. 
Moreover, the methods of data collection were 
consistent with the Health and Retirement Study and 
had a higher response rate. However, some limitations 
need to be addressed. First, chronic conditions/diseases 
were based on self-report. The self-reporting of somatic 
conditions may introduce some misclassification bias 
and underestimate the prevalence of SMM. However, 
self-report of diagnosed conditions is a common 
method for determining chronic conditions/diseases in 
epidemiological studies [14, 25]. In addition, Yuan et 
al. showed that self-reported diabetes had substantial 
agreement with fasting glucose and HbA1c levels in 
the CHARLS [37]. Second, some potential con-
founding factors need to be considered. We did not 
adjust for the severity of diseases or the number of 
medications. Third, 777 participants (11.5%) with 
complete baseline data were excluded from the study 
because they were lost to follow-up from 2013 to 2015, 
potentially causing selection bias. Finally, the long-
term trajectories of disability in ADL-IADL were not 
assessed. Because CHARLS is a relatively new 
longitudinal cohort, we used the two most recent 
waves. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The age-adjusted somatic-mental multimorbidity (SMM) prevalence by geographic location in China, 2013. 
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Table 3. Association between combination of somatic and mental conditions and ADL–IADL index. 
Multimorbidity combination groups 
Unadjusted  
eβ (95% CI) 
p value 
Adjusted*  
eβ (95% CI) 
p value 
Total population (n=6728)     
No somatic and mental conditions (n=940) Reference  Reference  
Only 1 somatic condition (n=1103) 1.27 (0.96-1.67) 0.089 1.24 (0.97-1.60) 0.091 
Somatic conditions multimorbidity (n=1687) 1.78 (1.39-2.27) <0.001 1.59 (1.28-1.97) <0.001 
Only 1 mental condition (n=413) 2.54 (1.92-3.34) <0.001 1.88 (1.46-2.41) <0.001 
Mental conditions multimorbidity (n=84) 4.05 (2.75-5.96) <0.001 2.09 (1.43-3.05) <0.001 
Somatic-mental multimorbidity (n=2501) 4.49 (3.60-5.59) <0.001 2.61 (2.12-3.22) <0.001 
Age 60-69 y (n=4495)     
No somatic and mental conditions (n=678) Reference  Reference  
Only 1 somatic condition (n=783) 1.51 (1.07-2.11) 0.017 1.35 (0.96-1.88) 0.081 
Somatic conditions multimorbidity (n=1152) 2.01 (1.48-2.72) <0.001 1.75 (1.33-2.32) <0.001 
Only 1 mental condition (n=236) 2.70 (1.85-3.95) <0.001 2.20 (1.52-3.18) <0.001 
Mental conditions multimorbidity (n=46) 4.09 (2.39-7.01) <0.001 2.35 (1.31-4.22) 0.004 
Somatic-mental multimorbidity (n=1600) 5.14 (3.91-6.76) <0.001 3.05 (2.29-4.07) <0.001 
Age 70+ y (n=2233)     
No somatic and mental conditions (n=262) Reference  Reference  
Only 1 somatic condition (n=320) 1.03 (0.67-1.58) 0.896 1.05 (0.71-1.54) 0.811 
Somatic conditions multimorbidity (n=535) 1.44 (0.98-2.12) 0.064 1.36 (0.99-1.86) 0.060 
Only 1 mental condition (n=177) 1.91 (1.27-2.89) 0.002 1.61 (1.12-2.32) 0.010 
Mental conditions multimorbidity (n=38) 3.16 (1.92-5.19) <0.001 1.94 (1.23- 3.05) 0.004 
Somatic-mental multimorbidity (n=901) 3.44 (2.44-4.86) <0.001 2.10 (1.55-2.85) <0.001 
Male (n=3383)     
No somatic and mental conditions (n=590) Reference  Reference  
Only 1 somatic condition (n=665) 1.64 (1.16-2.31) 0.005  1.42 (1.00-2.02) 0.047 
Somatic conditions multimorbidity (n=944) 1.99 (1.44-2.75) <0.001 1.63 (1.20-2.20) 0.002 
Only 1 mental condition (n=200) 3.03 (2.10-4.36) <0.001 2.28 (1.56-3.32) <0.001 
Mental conditions multimorbidity (n=25) 3.53 (1.89-6.60) <0.001 1.94 (1.09-3.43) 0.024 
Somatic-mental multimorbidity (n=959) 5.59 (4.25-7.36) <0.001 2.84 (2.15-3.75) <0.001 
Female (n=3345)     
No somatic and mental conditions (n=350) Reference  Reference  
Only 1 somatic condition (n=438) 0.98 (0.67-1.43) 0.901 1.04 (0.75-1.45) 0.792 
Somatic conditions multimorbidity (n=743) 1.58 (1.11-2.25) 0.012 1.53 (1.14-2.06) 0.005 
Only 1 mental condition (n=213) 1.99 (1.33-2.99) 0.001 1.63 (1.17-2.27) 0.004 
Mental conditions multimorbidity (n=59) 3.21 (1.98-5.22) <0.001 1.99 (1.28-3.11) 0.002 
Somatic-mental multimorbidity (n=1542) 3.34 (2.40-4.65) <0.001 2.36 (1.77-3.16) <0.001 
Urban residence (n=2472)     
No somatic and mental conditions (n=365) Reference  Reference  
Only 1 somatic condition (n=459) 0.92 (0.57-1.49) 0.725 0.94 (0.62-1.44) 0.781 
Somatic conditions multimorbidity (n=787) 1.59 (1.03-2.44) 0.036 1.33 (0.93-1.91) 0.120 
Only 1 mental condition (n=133) 3.32 (2.06-5.35) 0.001 2.20 (1.44-3.36) <0.001 
Mental conditions multimorbidity (n=14) 4.56 (2.02-10.28) <0.001 3.22 (1.07-9.69) 0.038 
Somatic-mental multimorbidity (n=714) 4.57 (3.04-6.88) <0.001 2.36 (1.61-3.47) <0.001 
Rural residence (n=4256)     
No somatic and mental conditions (n=575) Reference  Reference  
Only 1 somatic condition (n=644) 1.53 (1.10-2.11) 0.011 1.48 (1.11-1.99) 0.009 
Somatic conditions multimorbidity (n=900) 2.08 (1.57-2.74) <0.001 1.85 (1.46-2.35) <0.001 
Only 1 mental condition (n=280) 2.09 (1.50-2.93) <0.001 1.68 (1.28-2.21) <0.001 
Mental conditions multimorbidity (n=70) 3.64 (2.38-5.58) <0.001 2.07 (1.43-2.98) <0.001 
Somatic-mental multimorbidity (n=1787) 4.27 (3.32-5.48) <0.001 2.78 (2.23-3.47) <0.001 
*Models adjusted for complex survey design; adjusted for age-sex-education-marital status-smoking status-drinking status-
current residence-geographical region-and baseline ADL–IADL index. ADL = activities of daily living; IADL = instrumental 
activities of daily living; CI = confidence interval. 
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In conclusion, our findings show that the patterns of 
SMM combinations had different effects on disability in 
older Chinese adults. Moreover, multimorbidity 
combinations that included depression and/or cognitive 
impairment were associated with an increased risk of 
disability. 
 
MATERIALS AND METHODS 
 
Study cohort 
 
The current study was based on the China Health and 
Retirement Longitudinal Study (CHARLS) [38]. A 
more detailed description of the cohort has been 
published elsewhere [38, 39]. Briefly, a multistage, 
stratified and cluster sampling approach was used to 
obtain this community-based, longitudinal prospective 
study. Participants were recruited from 6 geographical 
regions of 28 provinces of China: (1) East (Shanghai, 
Shandong, Jiangsu, Zhejiang, Fujian, Anhui, and 
Jiangxi); (2) North (Beijing, Tianjin, Hebei, Shanxi, and 
Inner Mongolia); (3) Northeast (Liaoning, Jilin, and 
Heilongjiang); (4) Northwest (Shaanxi, Gansu, Qinghai, 
and Xinjiang); (5) South-Central (Henan, Hubei, 
Hunan, Guangdong, and Guangxi); and (6) Southwest 
(Chongqing, Sichuan, Guizhou, and Yunnan). A 
computer-aided self-administered questionnaire was 
used to collect data on sociodemographic charac-
teristics, lifestyle characteristics, health behaviors, 
chronic diseases, physical function and mental health 
conditions. The CHARLS national baseline survey was 
conducted from June 2011 to March 2012 (Wave 1). 
The above information was repeatedly collected every 2 
years. All participants provided written informed 
consent. This study was approved by the Biomedical 
Ethics Review Committee of Peking University 
(IRB00001052-11015). 
 
Study population 
 
In Wave 2 (2013), 18612 individuals aged 45 years or 
over were initially included. The current analysis was 
limited to 8658 participants who were younger than 60 
years of age. We excluded participants who had 
incomplete data related to the assessment of chronic 
diseases, depression, cognitive function, disability at 
baseline, follow-up or loss to follow-up in Wave 3 
(2015). Finally, a sample of 6728 participants was 
included in the current analysis. A flowchart of the 
selected participants is shown in Figure 2. 
 
Disability assessment 
 
Disability was assessed using a modified version of the 
Katz Index of Independence in Activities of Daily 
Living (ADL) [40] and the Lawton Instrumental 
Activities of Daily Living (IADL) Scale [41]. 
Participants were asked whether they had difficulty or 
needed help performing 6 ADLs (dressing, bathing, 
eating, getting in and out of bed, toileting, and 
incontinence) and 5 IADLs (managing money, taking 
medications, grocery shopping, preparing meals, and 
making phone calls). Both ADLs and IADL were 
assessed at baseline (Wave 2, 2013) and follow-up 
(Wave 3, 2015). The ADL-IADL index was calculated 
by summing the number of impairment activities in 
ADL and IADL for each participant who had at least 
one no missing item on the ADL and IADL instruments 
(range: 0-11) [14]. A higher ADL-IADL index 
represented a greater disability severity. 
 
Somatic conditions/diseases 
 
Self-reported physician-diagnosed diseases in 2013 or 
prior prompted by “Has a doctor ever told you that you 
have…,” included hypertension, diabetes, cancer or a 
malignant tumor (excluding minor skin cancers), 
chronic lung disease, heart disease (heart attack, 
coronary heart disease, angina, congestive heart failure, 
or other heart problems), stroke, arthritis, dyslipidemia 
(elevation of low density lipoprotein, triglycerides, and 
total cholesterol, or a low high density lipoprotein 
level), liver disease (except fatty liver, tumors, and 
cancer), kidney disease (except for tumor or cancer), 
digestive disease (except for tumor or cancer), and 
asthma. 
 
Mental health conditions 
 
Mental health conditions, including depression and 
cognitive impairment, were assessed in 2013. 
 
Depression 
 
We used two types of information to identify whether 
participants were depressed in 2013: (1) self-report of 
physician-diagnosed psychiatric problems and (2) the 
10-item Center for Epidemiological Studies Depression 
Scale (CESD-10) [42]. The CESD-10 scores were 
calculated by summing the responses to each question: 
0 = rarely or none of the time (less than 1 day), 
1 = some or a little of the time (1-2 days), 
2 = occasionally or a moderate amount of time (3-4 
days), 3 = most or all of the time (5-7 days). The CESD-
10 scores ranged from 0 to 30, with higher scores 
indicating that the participant felt more negatively 
during the past week. As suggested by a previous study 
[43], a score of ≥ 10 on the CESD-10 indicated  
a positive screen for depressive symptoms in older 
Chinese adults. Depression was defined as having  
either self-reported psychiatric problems or a CESD-10 
score ≥ 10. 
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Cognitive impairment 
 
Cognitive impairment was defined as having either self-
reported dementia or Alzheimer’s disease diagnosed by 
a doctor or impairment in at least 2 cognitive tests. Three 
tests were administered: (1) the Telephone Interview of 
Cognitive Status (TICS-10) (range: 0-10); (2) word 
recall (range: 0-10); and (3) figure drawing (yes=1, 
no=0). A detailed description of the cognitive 
assessments used in the CHARLS was published 
previously [44, 45]. Impairment on each cognitive test 
was defined as scores at or below 1.5 standard deviations 
(SD) from the mean for the CHARLS study sample. 
Score cutoff points for ≤ 1.5 SD below the mean on each 
cognitive test are shown in Supplementary Table 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Definition of multimorbidity 
 
Following previous studies [20, 25], we defined general 
multimorbidity as the presence of 2 or more of the 14 
conditions in CHALRS 2013. Similarly, we defined 
SMM as any combination of two or more conditions in 
which at least one condition was somatic and at least 
one condition was mental. 
 
Covariates 
 
Sociodemographic characteristics included age, sex, 
education (less than lower secondary, upper secondary, 
and vocational training, and tertiary), marital status 
(married and others: widowed, separated,  divorced  and  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Flowchart of selection of study participants. 
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never married), current residence (urban and rural area), 
and geographical region. Lifestyle variables included 
self-reported smoking and drinking status (never, ever, 
and current). BMI was calculated as weight in 
kilograms divided by height in meters squared. The 
baseline ADL-IADL index indicated the severity of 
disability reported in 2013. 
 
Statistical analysis 
 
All analyses were performed using Stata 15 software 
(College Station, TX). A p-value <0.05 was considered 
Statistically significant. Descriptive statistics were 
presented as the mean (standard deviation) for continuous 
variables and percentage for categorical variables. 
 
We first estimated the sex-specific prevalence of SMM 
in the overall population and then according to age 
group (60-64, 65-69, 70-74, 75+ years) and current 
residence. The χ2 test was used to compare the crude 
prevalence. We also identified the prevalence of SMM 
by geographical region, adjusting for age as a 
continuous variable in logistic regression. We used the 
“svy: tabulate” and “svy: logit” procedures in Stata to 
estimate the prevalence while taking the complex 
survey design and the nonresponse rate of the CHARLS 
survey into account. 
 
In order to assess the impact of different combinations 
of SMM in 2013 and ADL-IADL disability in 2015, the 
combinations identified in 2013 are presented in 
Supplementary Figure 1. As the outcome variable was a 
count variable, a negative binomial regression model 
(NBRM) was fitted for complex survey design and 
overdispersion to investigate the impact of multi-
morbidity combinations in 2013 on the ADL-IADL 
index in 2015. NBRM was conducted using the “svy: 
nbreg” procedure in Stata. Two models were built. 
Model 1 was unadjusted, and Model 2 was adjusted for 
age (continuous), sex, education, marital status, 
smoking status, drinking status, current residence, 
geographical region, and baseline ADL-IADL index. 
We reported the exponentiated regression coefficients 
and corresponding 95% CIs, representing the difference 
in the number of ADL-IADL impairments between each 
multimorbidity combination group compared to healthy 
participants (reference). 
 
A stratified analysis was performed by age group (< 70 
and ≥ 70 years), sex (male and female), and current 
residence (urban and rural area). The cutoff age of 70 
years was chosen because it was close to the average 
age of the study population (mean: 68 years). 
Interaction terms between multimorbidity combination 
groups and the above subgroups were added in the 
multivariable model, and a p-value for interaction was 
obtained from the likelihood test by comparing models 
with and without the interaction term. 
 
Three sensitivity analyses were conducted: (1) because 
incontinence is more likely to be considered an organic 
disorder rather than a disability in clinical practice [46], 
we recalculated the ADL-IADL index (range: 0-10) by 
removing incontinence; (2) we additionally adjusted for 
BMI (continuous) in the subpopulation with complete 
data for BMI (n=5320); and (3) we excluded 
participants who had at least one impairment in the 
ADL-IADL index in 2013 (n=4061). 
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SUPPLEMENTARY MATERIALS 
 
Supplementary Figure 
 
 
 
 
 
 
 
Supplementary Figure 1. Model showing the grouping of somatic and mental conditions/diseases. Participants were grouped by 
the number of somatic conditions (SC) and mental conditions (MC). Mult., multimorbidity; Ref., reference group; SMM, somatic-mental 
multimorbidity. 
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Supplementary Tables 
 
Supplementary Table 1. Sensitivity analyses of association between combination of somatic and mental conditions 
and ADL–IADL index. 
Multimorbidity combination groups 
Adjusted*  
eβ (95% CI) 
p  
value 
Sensitivity analyses 1: removing incontinence from ADL-IADL index (n=6728) 
No somatic and mental conditions (n=940) Reference  
Only 1 somatic condition (n=1103) 1.25 (0.98-1.61) 0.076 
Somatic conditions multimorbidity (n=1687) 1.56 (1.27-1.93) <0.001 
Only 1 mental condition (n=413) 1.86 (1.45-2.39) <0.001 
Mental conditions multimorbidity (n=84) 2.04 (1.39-3.00) <0.001 
Somatic-mental multimorbidity (n=2501) 2.52 (2.06-3.08) <0.001 
Sensitivity analyses 2: additionally adjusted for body mass index (continuous) (n=5320) 
No somatic and mental conditions (n=756) Reference  
Only 1 somatic condition (n=873) 1.14 (0.85-1.53) 0.373 
Somatic conditions multimorbidity (n=1339) 1.56 (1.22-2.00) <0.001 
Only 1 mental condition (n=326) 1.73 (1.31-2.29) <0.001 
Mental conditions multimorbidity (n=66) 1.85 (1.21-2.81) 0.004 
Somatic-mental multimorbidity (n=1960) 2.57 (2.04-3.25) <0.001 
Sensitivity analyses 3: excluding participants who had at least one impairment in ADL-IADL index in 2013 (n=4061) 
No somatic and mental conditions (n=772) Reference  
Only 1 somatic condition (n=818) 1.12 (0.79-1.59) 0.532 
Somatic conditions multimorbidity (n=1147) 1.38 (1.03-1.85) 0.031 
Only 1 mental condition (n=239) 1.92 (1.36-2.73) <0.001 
Mental conditions multimorbidity (n=30) 2.20 (0.95-5.11) 0.065 
Somatic-mental multimorbidity (n=1055) 2.99 (2.27-3.95) <0.001 
*Models adjusted for complex survey design; adjusted for age-sex-education-marital status-smoking status-drinking status-
current residence-geographical region-and baseline ADL–IADL index. ADL = activities of daily living; IADL = instrumental 
activities of daily living; CI = confidence interval. 
 
Supplementary Table 2. Score cutpoints for ≤ 1.5 SDs below mean on  
cognitive tests. 
 TICS-10 Word-recall Figure-drawing 
Score range 0-10 0-10 0-1 
Score mean 5.95 3.26 0.17 
Score SD 3.10 1.79 0.38 
Score cutpoints ≤1 ≤1 0 
 
 
 
